Supplementary Fig S10 from CLDN6 Expression Plasticity in Ovarian Cancer: Insights into Therapeutic Optimization for CLDN6-Targeted Immunotherapy
Abstract
Histopathological and immunohistochemical analysis of NIH:OVCAR-3 xenograft tumors following vehicle or carboplatin treatment
Fields of Study & Subjects
Ovarian cancer diagnosis and treatment
Cancer Immunotherapy and Biomarkers
Cancer Cells and Metastasis
Publication details
- Publication date
- 25 February 2026
- Language
- EN